IBDV antibody (Biotin)
Quick Overview for IBDV antibody (Biotin) (ABIN2177007)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Virus
-
Cross-Reactivity (Details)
- IBDV
-
Purification
- Purified by Protein A.
-
Immunogen
- Derived from IBDV vaccine strain B87
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IHC-P 1:200-400
IHC-F 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C for 12 months.
-
Expiry Date
- 12 months
-
-
- IBDV
-
Target Type
- Virus
-
Background
-
Synonyms: Infectious Bursal Disease Vaccine,infectious bursal disease, IBD.
Background: Infectious bursal disease (IBD) is caused by infectious bursal disease virus (IBDV) an avian Birnavirus first described in the USA near the town of Gumboro Delaware and thus the disease is also known as Gumboro disease. There are 3 recognized pathogenic types of IBDV, classic virulent (cvIBDV), sub-clinical (scIBDV), and very virulent (vvIBDV). All three pathogenic types of IBDV cause immune suppression which leads to secondary infections and a failure to produce an immune response to vaccines. The cvIBDV typically cause a high morbidity and low mortality disease while the scIBDV cause very little morbidity and no mortality. The vvIBDV cause an acute disease in chickens characterized by high morbidity and high mortality.
Target
-
